Followers | 306 |
Posts | 62144 |
Boards Moderated | 10 |
Alias Born | 08/29/2007 |

Saturday, October 26, 2024 2:14:37 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent LENZ News
- LENZ Therapeutics to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/27/2025 12:00:00 PM
- LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia • GlobeNewswire Inc. • 05/09/2025 01:03:48 PM
- LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 05/07/2025 08:05:00 PM
- LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference • GlobeNewswire Inc. • 05/06/2025 08:30:48 PM
- LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025 • GlobeNewswire Inc. • 04/30/2025 08:30:00 PM
- Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors • GlobeNewswire Inc. • 04/01/2025 11:00:00 AM
- LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/19/2025 08:05:00 PM
- LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 • GlobeNewswire Inc. • 03/11/2025 12:00:00 PM
- LENZ Therapeutics to Host Commercial Day on April 15, 2025 • GlobeNewswire Inc. • 03/03/2025 01:00:00 PM
- LENZ Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2025 01:00:00 PM
- LENZ Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- LENZ Therapeutics Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024 • GlobeNewswire Inc. • 10/30/2024 12:00:00 PM
- CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100 • GlobeNewswire Inc. • 10/28/2024 01:00:00 AM
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia • GlobeNewswire Inc. • 10/21/2024 12:00:00 PM
- LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences • GlobeNewswire Inc. • 09/30/2024 12:00:00 PM
- LENZ Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/27/2024 08:01:00 PM
- LENZ Therapeutics Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 • GlobeNewswire Inc. • 08/07/2024 08:01:00 PM
- LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital • GlobeNewswire Inc. • 07/15/2024 12:00:00 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM